Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | CA4 | P22748 | 5/20 | 1.00 |
| ▸ | CA7 | P43166 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TYR | P14679 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 0.86 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.84 |
| ▸ | P4HB | P07237 | 4/20 | 0.70 |
| ▸ | ACHE | P22303 | 1/20 | 0.70 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.69 |
| ▸ | POLB | P06746 | 3/20 | 0.67 |
| ▸ | GAA | P10253 | 3/20 | 0.67 |
| ▸ | APEX1 | P27695 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | XDH | P47989 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | CBS | P35520 | 1/20 | 0.66 |
| ▸ | NQO2 | P16083 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiliroside SCHEMBL28142584 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL29366630 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL23598 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL23597 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL13963382 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL16131015 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL31082442 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL12568460 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| Tiliroside SCHEMBL15756208 | 1.00 | CA12 (1.00) | CA12CA4CA7CYP3A4TYR | |
| SCHEMBL18922182 | 0.96 | CA12 (0.93) | CA12CA4CA7CYP3A4TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118384081-B | Application of flos Magnoliae extract containing small molecular compounds in preparing alopecia preventing product or washing product | 长春中医药大学 | 2024-09-17 | — | — | CN | disclosed |
| CN-118384081-A | Application of flos Magnoliae extract containing small molecular compounds in preparing alopecia preventing product or washing product | 长春中医药大学 | 2024-07-26 | — | — | CN | disclosed |
| US-8946457-B2 | Flavone derivatives and their preparative method and medical use | TIANJIN MEDICAL UNIVERSITY (CN) | 2015-02-03 | — | — | US | disclosed |
| US-8946457-B2 | Flavone derivatives and their preparative method and medical use | TIANJIN MEDICAL UNIVERSITY (CN) | 2015-02-03 | — | — | US | disclosed |
| US-20130231492-A1 | FLAVONE DERIVATIVES AND THEIR PREPARATIVE METHOD AND MEDICAL USE | TIANJIN MEDICAL UNIVERSITY (CN) | 2013-09-05 | — | — | US | disclosed |
| US-20130231492-A1 | FLAVONE DERIVATIVES AND THEIR PREPARATIVE METHOD AND MEDICAL USE | TIANJIN MEDICAL UNIVERSITY (CN) | 2013-09-05 | — | — | US | disclosed |
| US-7960430-B2 | Flavonoid complexes with cyclodextrins | MERCK PATENT GMBH (DE) | 2011-06-14 | — | — | US | disclosed |
| US-20070155695-A1 | Flavonoid complexes with cyclodextrins | EUROPEAN BRAND PARTICIPATIONS SA (LU) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231492-A1 | FLAVONE DERIVATIVES AND THEIR PREPARATIVE METHOD AND MEDICAL USE | SLC2A4, GOT1, SLC2A2 | CA12 4447/4885CA4 1167/4885CA7 2903/4885 |
| US-20070155695-A1 | Flavonoid complexes with cyclodextrins | TYR, DPM1, CYP2F1 | CA12 2907/4885CA4 1134/4885CA7 1343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.